RHD and rheumatic heart disease: Though useful as there have been drastic reductions in the incidence of RhD immunization since the inception of the anti-D immunoglobulin prophylaxis, the disadvantages associated with unsighted administration of the prophylaxis underpin the need for prenatal fetal RhD genotyping.